DexCom, Inc. logo DXCM - DexCom, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 1
BUY 41
HOLD 8
SELL 2
STRONG
SELL 0
| PRICE TARGET: $78.25 DETAILS
HIGH: $92.00
LOW: $64.00
MEDIAN: $78.50
CONSENSUS: $78.25
UPSIDE: 8.53%

Stock News

Dexcom: A Medical Platform Play Gaining From AI, Not Disrupted By It

Dexcom: A Medical Platform Play Gaining From AI, Not Disrupted By It

Dexcom (DXCM) is leveraging AI to drive operational efficiency and product innovation, positioning itself as a platform medical provider in CGM. DXCM achieved 300 basis points in operating margin improvement, with sustained cost savings and strong FCF margin outpacing healthcare equipment peers. Stelo CGM, built with Google AI, targets the large prediabetic market, offering significant customer base expansion potential without requiring a prescription.

May 22, 2026 01:40 PM • seekingalpha.com
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

SAN DIEGO & EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using intensive insulin therapy. The new system will be available in Germany soon. Dexcom Flex is made for people using basal insulin, oral medications or GLP-1 receptor agonists, expanding access to CGM technology for a broader Type 2 diabetes population. D.

May 18, 2026 03:31 AM • businesswire.com
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced key updates to its governance structure in conjunction with its upcoming 2026 Investor Day presentation that outlines a strategic and financial vision to best position the company for future growth. “We look forward to articulating our exciting vision for growth later today at Investor Day as we seek to empower greater metabolic health through our biosensing platforms,” said Jake Leach, Dexcom's president and CEO. “Today's a.

May 14, 2026 12:02 PM • businesswire.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More

Pre-Market Stock Futures: The futures are trading lower on Tuesday, but another week and another set of new highs for the S&P 500 and the Nasdaq, as AI fever overshadowed Iran's peace counteroffer dismissal on Monday. The stock market opened lower on the rejection of President Trump's peace offering, but buyers once again circled the... Here Are Tuesday's Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe's, Matador Resources, Toast and More

May 12, 2026 03:54 AM • 247wallst.com
3 Reasons Analysts Love DexCom

3 Reasons Analysts Love DexCom

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a crucial component of a broader set of tools to address type 2 diabetes. With about 40 million people in the United States suffering from diabetes, and incidents of type 2 diabetes rising across multiple demographics, this core function of this class of medicines is still just as relevant as it was when these drugs first became available.

May 05, 2026 08:25 AM • marketbeat.com
Dexcom to Host Investor Day on May 14, 2026

Dexcom to Host Investor Day on May 14, 2026

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it will host an Investor Day on Thursday, May 14, 2026 from 1:15 PM until approximately 3:30 PM PDT (4:15 PM – 6:30 PM EDT). The event will include presentations from Dexcom management highlighting the company's market opportunities, business strategy, innovation efforts, and long-term financial outlook. Links to a live webcast of the event will be available on the Dexcom Investor Relations website at investors.dexcom.c.

May 05, 2026 04:30 AM • businesswire.com

Price Targets